To our knowledge, the relationship between peripheral/CSF ApoA1 and biomarkers of neurodegeneration or NFT pathology has been reported only in one longitudinal study on 429 individuals with subjective cognitive decline or MCI [45]. The gene discussed is APOA1; the disease is Mental deterioration.